Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00140868 · ClinicalTrials.gov registry record · Phase 3

Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery

A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 3
Development phase
180
Enrollment target

NCT00140868: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00140868 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00140868, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
180 participants
Enrollment target

Study Summary

The purpose of this study is to assess quality of life and bowel symptoms after treatment.The main objective is to compare the effect on quality of life of minimally invasive bowel surgery and endoscopic stent placement in the treatment of malignant large bowel obstruction.

Interventions

  • DEVICE Luminal stents
  • PROCEDURE Minimally Invasive Surgical Bowel Diversion

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2002-12
Est. Completion 2006-10
Phase Phase 3

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00140868

The ClinicalTrials.gov registry entry for NCT00140868 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Luminal stents is the first listed.

NCT00140868 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00140868 about?

NCT00140868 is a clinical study titled "Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery". The purpose of this study is to assess quality of life and bowel symptoms after treatment.The main objective is to compare the effect on quality of life of minimally invasive bowel surgery and endoscopic stent placement in the treatment of malignant large bowel obstruction.

What is the current status of trial NCT00140868?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 180 participants. The study started on 2002-12. Estimated completion is 2006-10.

What interventions are being tested in trial NCT00140868?

The interventions under investigation include: Luminal stents (DEVICE), Minimally Invasive Surgical Bowel Diversion (PROCEDURE).

Who is sponsoring clinical trial NCT00140868?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.